U.S. Markets closed

XTL Biopharmaceuticals Ltd. (XTLB)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.57+0.01 (+0.37%)
At close: 4:00PM EDT
People also watch
ZSANMBRXBNTCMYOSOCRX
Interactive chart
Previous Close2.56
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range2.57 - 2.57
52 Week Range1.93 - 7.85
Volume163
Avg. Volume64,503
Market Cap13.92M
Beta0.17
PE Ratio (TTM)-2.86
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 years ago

    XTL Biopharmaceuticals Ltd. Earnings Q2, 2015

    XTL Biopharmaceuticals Ltd. reports preliminary financial results for the quarter ended June 30, 2015.We analyze the earnings along side the following peers of XTL Biopharmaceuticals Ltd. Sponsored ADR – Bristol-Myers Squibb Company, Vertex Pharmaceuticals Incorporated, Anthera Pharmaceuticals, Inc., GlaxoSmithKline plc Sponsored ADR, Merck & Co., Inc., Astrazeneca PLC Sponsored ADR, Eli Lilly and Company, Teva […] (Read more...) The post XTL Biopharmaceuticals Ltd. Earnings Q2, 2015 appeared first on CapitalCube.

  • 24/7 Wall St.2 years ago

    4 Speculative Biotechs With Huge Analyst Targets

    Among speculative small-cap biotechs, analyst calls are often accompanied with upside price targets of 50%, 100% or even 200%. This is because the companies are often all-in bets on one or two treatments....

  • Benzinga2 years ago

    XTL Biopharmaceuticals Aims To Tame Lupus, HC Wainwright Initiates At Buy

    In a report published Friday, analyst Swayampakula Ramakanth of HC Wainwright & Co initiated coverage of XTL Biopharmaceuticals Ltd (NASDAQ: XTLB ) with a Buy rating and a price target of $6. Of the three ...